Home › Funds › Rock Springs Capital Management LP › MDGL
Rock Springs Capital Management LP position in MDGL
MADRIGAL PHARMACEUTICALS INC · Health Care
Rock Springs Capital Management LP reported holding 177,249 shares of MDGL (MADRIGAL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$89.3M, representing 4.83% of its reported portfolio and ranking #4 among its reported holdings. Rock Springs Capital Management LP has disclosed MDGL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Rock Springs Capital Management LP's MDGL position evolved
Rock Springs Capital Management LP first disclosed a stake in MDGL in Q3 2023 at 196,369 shares (US$28.7M). The position peaked in Q2 2026 at 174,999 shares, worth US$94.0M. Across 13 filings, Rock Springs Capital Management LP increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 177,249 shares valued at US$89.3M — an increase of 2,250 shares quarter over quarter.. Notable position changes include a 44% increase in Q1 2024 (shares rose 5% over the following quarter), a 37% trim in Q1 2025 (shares fell 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 196.37K | $28.68M | New |
| Q4 2023 | 198.17K | $45.85M | Add |
| Q1 2024 | 285.93K | $76.36M | Add |
| Q2 2024 | 245.50K | $68.78M | Reduce |
| Q3 2024 | 263.06K | $55.83M | Add |
| Q4 2024 | 265.21K | $81.84M | Add |
| Q1 2025 | 166.70K | $55.22M | Reduce |
| Q2 2025 | 140.30K | $42.46M | Reduce |
| Q3 2025 | 137.75K | $63.18M | Reduce |
| Q4 2025 | 139.62K | $81.31M | Add |
| Q1 2026 | 171.00K | $89.51M | Add |
| Q2 2026 | 175.00K | $93.97M | Add |
| Q3 2026 | 177.25K | $89.33M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MDGL and 13F data
MDGL (MADRIGAL PHARMACEUTICALS INC) is a Health Care company. 45 other funds we track also report a position in MDGL — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.15B), Janus Henderson Group (US$1.05B), Jupiter Topco LLC (US$1.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MDGL
- BAKER BROS. ADVISORS LP 2.14M sh · $1.15B · Q2 2026
- Janus Henderson Group 2.02M sh · $1.05B · Q1 2026
- Jupiter Topco LLC 1.94M sh · $1.04B · Q2 2026
- Avoro Capital Advisors LLC 1.83M sh · $923.93M · Q3 2026
- Paulson & Co 1.34M sh · $719.52M · Q2 2026
- PAULSON & CO. INC. 1.34M sh · $719.52M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 337.04K sh · $169.85M · Q3 2026
- RTW INVESTMENTS, LP 312.82K sh · $157.65M · Q3 2026
- Hood River Capital Management LLC 170.68K sh · $86.02M · Q3 2026
More on Rock Springs Capital Management LP
FAQ
How long has Rock Springs Capital Management LP held MDGL?
Rock Springs Capital Management LP has disclosed MDGL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Rock Springs Capital Management LP's current position in MDGL?
As of Q3 2026, Rock Springs Capital Management LP holds 177.25K shares of MDGL (MADRIGAL PHARMACEUTICALS INC), valued at $89.33M, representing 4.83% of its reported portfolio and ranking #4.
Has Rock Springs Capital Management LP been buying or selling MDGL?
In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP increased its position in MDGL. The position peaked in Q2 2026 at 175.00K shares.
Which other funds hold MDGL?
Other major institutional holders of MDGL include BAKER BROS. ADVISORS LP, Janus Henderson Group, Jupiter Topco LLC, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.